These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23077590)

  • 1. Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma.
    Abushahba W; Olabisi OO; Jeong BS; Boregowda RK; Wen Y; Liu F; Goydos JS; Lasfar A; Cohen-Solal KA
    PLoS One; 2012; 7(10):e47312. PubMed ID: 23077590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibition.
    Cohen-Solal KA; Merrigan KT; Chan JL; Goydos JS; Chen W; Foran DJ; Liu F; Lasfar A; Reiss M
    Pigment Cell Melanoma Res; 2011 Jun; 24(3):512-24. PubMed ID: 21477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
    van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
    Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta).
    Clifford RL; Deacon K; Knox AJ
    J Biol Chem; 2008 Dec; 283(51):35337-53. PubMed ID: 18952601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells.
    Le MN; Chan JL; Rosenberg SA; Nabatian AS; Merrigan KT; Cohen-Solal KA; Goydos JS
    J Invest Dermatol; 2010 Sep; 130(9):2240-9. PubMed ID: 20505744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
    Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
    Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent Targeting of Glutaminolysis and Metabotropic Glutamate Receptor 1 (GRM1) Reduces Glutamate Bioavailability in GRM1
    Shah R; Singh SJ; Eddy K; Filipp FV; Chen S
    Cancer Res; 2019 Apr; 79(8):1799-1809. PubMed ID: 30987979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor β-mediated site-specific Smad linker region phosphorylation in vascular endothelial cells.
    Kamato D; Rostam MA; Piva TJ; Babaahmadi Rezaei H; Getachew R; Thach L; Bernard R; Zheng W; Little PJ; Osman N
    J Pharm Pharmacol; 2014 Dec; 66(12):1722-33. PubMed ID: 25316549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
    Yang F; Chung AC; Huang XR; Lan HY
    Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells.
    Wall BA; Wangari-Talbot J; Shin SS; Schiff D; Sierra J; Yu LJ; Khan A; Haffty B; Goydos JS; Chen S
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):263-74. PubMed ID: 24330389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signaling.
    Nyati S; Schinske K; Ray D; Nyati MK; Ross BD; Rehemtulla A
    Clin Cancer Res; 2011 Dec; 17(23):7424-39. PubMed ID: 21948232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways.
    Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J
    J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saponins from the roots of Platycodon grandiflorum suppresses TGFβ1-induced epithelial-mesenchymal transition via repression of PI3K/Akt, ERK1/2 and Smad2/3 pathway in human lung carcinoma A549 cells.
    Choi JH; Hwang YP; Kim HG; Khanal T; Do MT; Jin SW; Han HJ; Lee HS; Lee YC; Chung YC; Jeong TC; Jeong HG
    Nutr Cancer; 2014; 66(1):140-51. PubMed ID: 24341702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
    Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
    Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle.
    Rezaei HB; Kamato D; Ansari G; Osman N; Little PJ
    Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):661-7. PubMed ID: 21883378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phosphorylation of the Smad2/3 linker region by nemo-like kinase regulates TGF-β signaling.
    Liang J; Zhou Y; Zhang N; Wang D; Cheng X; Li K; Huang R; Lu Y; Wang H; Han D; Wu W; Han M; Miao S; Wang L; Zhao H; Song W
    J Biol Chem; 2021; 296():100512. PubMed ID: 33676893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.
    Wen Y; Li J; Koo J; Shin SS; Lin Y; Jeong BS; Mehnert JM; Chen S; Cohen-Sola KA; Goydos JS
    Cancer Res; 2014 May; 74(9):2499-509. PubMed ID: 24491800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies.
    Lee HJ; Wall BA; Wangari-Talbot J; Shin SS; Rosenberg S; Chan JL; Namkoong J; Goydos JS; Chen S
    Clin Cancer Res; 2011 Nov; 17(22):7080-92. PubMed ID: 21844014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A negative feedback control of transforming growth factor-beta signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204.
    Millet C; Yamashita M; Heller M; Yu LR; Veenstra TD; Zhang YE
    J Biol Chem; 2009 Jul; 284(30):19808-16. PubMed ID: 19458083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.